MoneyWorks4Me

Mankind Pharma - Quaterly Results

31 Jul 2024 Evaluate
The revenue zoomed 14.86% to Rs. 24032.60 millions for the quarter ended June 2024 as compared to Rs. 20922.80 millions during the corresponding quarter last year.Net Profit recorded in the quarter ended June 2024 rise to 27.51% to Rs. 4842.50  millions  compared to R. 3797.80 millions in corresponding previous quarter.Operating profit for the quarter ended June 2024 rose to 6670.30 millions as compared to 5554.00 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 24032.60 20922.80 14.86 24032.60 20922.80 14.86 92648.09 81271.53 14.00
Other Income 948.30 574.40 65.09 948.30 574.40 65.09 2666.38 1627.83 63.80
PBIDT 6670.30 5554.00 20.10 6670.30 5554.00 20.10 25917.44 18601.65 39.33
Interest 62.60 19.70 217.77 62.60 19.70 217.77 145.70 277.48 -47.49
PBDT 6607.70 5534.30 19.40 6607.70 5534.30 19.40 25771.74 18324.17 40.64
Depreciation 834.00 685.10 21.73 834.00 685.10 21.73 3176.06 2695.80 17.82
PBT 5773.70 4849.20 19.07 5773.70 4849.20 19.07 22595.68 15628.37 44.58
TAX 931.20 1051.40 -11.43 931.20 1051.40 -11.43 4361.57 3145.79 38.65
Deferred Tax -152.20 137.80 -210.45 -152.20 137.80 -210.45 195.98 229.43 -14.58
PAT 4842.50 3797.80 27.51 4842.50 3797.80 27.51 18234.11 12482.58 46.08
Equity 400.59 400.59 0.00 400.59 400.59 0.00 400.59 400.59 0.00
PBIDTM(%) 27.76 26.55 4.56 27.76 26.55 4.56 27.97 22.89 22.22
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..